Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DU MONT AUX MALADES : revenue, balance sheet and financial ratios

SELARL PHARMACIE DU MONT AUX MALADES is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONT-SAINT-AIGNAN (76130), this company of category PME shows in 2025 a net income positive of 85 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELARL PHARMACIE DU MONT AUX MALADES (SIREN 908585243)
Kennzahl 2025 2024 2023
Umsatz N/C N/C N/C
Nettoergebnis 84 715 € 149 566 € 204 525 €
EBITDA N/C N/C N/C
Nettomarge N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2025, SELARL PHARMACIE DU MONT AUX MALADES generates positive net income of 85 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2025: 205 k€ -> 85 k€.

Nettoergebnis (2025) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

84 715 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 254%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory.

Verschuldungsgrad (2025) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

254.292%

Finanzielle Autonomie (2025) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

25.183%

Anlagenaltersquote (2025) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

33.2%

Entwicklung der Solvenzkennzahlen
SELARL PHARMACIE DU MONT AUX MALADES

Positionnement sectoriel

Debt ratio
254.29 2025
2023
2024
2025
Q1: 13.7
Méd: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of SELARL PHARMACIE DU MONT ... (254.29) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
25.18% 2025
2023
2024
2025
Q1: 33.42%
Méd: 53.72%
Q3: 72.08%
Watch

In 2025, the financial autonomy of SELARL PHARMACIE DU MONT ... (25.2%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 173.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2025) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

173.803

Entwicklung der Liquiditätskennzahlen
SELARL PHARMACIE DU MONT AUX MALADES

Positionnement sectoriel

Liquidity ratio
173.8 2025
2023
2024
2025
Q1: 131.03
Méd: 182.25
Q3: 258.64
Average +13 pts über 3 Jahre

In 2025, the liquidity ratio of SELARL PHARMACIE DU MONT ... (173.80) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positionnement de SELARL PHARMACIE DU MONT AUX MALADES dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE DU MONT AUX MALADES is estimated at 1 345 707 € (range 913 203€ - 2 111 600€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
913k€ 1345k€ 2111k€
1 345 707 € Range: 913 203€ - 2 111 600€
NAF 5 année 2025

Valuation method used

Net Income Multiple
84 715 € × 15.9x = 1 345 708 €
Range: 913 204€ - 2 111 601€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DU MONT AUX MALADES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DU MONT AUX MALADES

What is the revenue of SELARL PHARMACIE DU MONT AUX MALADES ?

The revenue of SELARL PHARMACIE DU MONT AUX MALADES is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DU MONT AUX MALADES profitable?

Yes, SELARL PHARMACIE DU MONT AUX MALADES generated a net profit of 85 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE DU MONT AUX MALADES ?

The headquarters of SELARL PHARMACIE DU MONT AUX MALADES is located in MONT-SAINT-AIGNAN (76130), in the department Seine-Maritime.

Where to find the tax return of SELARL PHARMACIE DU MONT AUX MALADES ?

The tax return of SELARL PHARMACIE DU MONT AUX MALADES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DU MONT AUX MALADES operate?

SELARL PHARMACIE DU MONT AUX MALADES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.